Proactive Investors - Run By Investors For Investors

NetScientific boss proud of cancer diagnostic tool's achievements

NetScientific PLC (LON:NSCI) boss François Martelet talks Proactive through news its flagship company Vortex Biosciences has begun the commercial launch of its VTX1 Liquid Biopsy system.
It's the first time  Netscientific has been able to market a cancer diagnostic instrument and it has been executed on time and in line with market expectations, he says.
"It's a very fast and simple way to isolate and collect intact CTCs directly from the whole blood," he says.

 
Meet Rockfire Resources PLC, Touchstone Exploration Inc, Mkango Resources Ltd and Salt Lake Potash Ltd at our event, London , 20 June 2019. Register here »
View full NSCI profile View Profile

Netscientific PLC Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use